# FDA Inspection 1169898 - Delta Pharma, Inc. - May 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/79d66fe7-f3d0-4dd0-9136-9d0c83bd51c0
Source feed: FDA_Inspections

> FDA Inspection 1169898 for Delta Pharma, Inc. on May 20, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169898
- Company Name: Delta Pharma, Inc.
- Inspection Date: 2022-05-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1292232 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/80d920f8-4805-4a4a-bd47-6f597d08fdc2)
- [FDA Inspection 1235500 - 2024-04-12](https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/3856282d-e9b3-4734-bb19-f1f6b2ce916c)
- [FDA Inspection 1206930 - 2023-06-02](https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/1742a409-2a5d-4b11-aec6-e7765861703b)
- [FDA Inspection 1004804 - 2017-02-23](https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/734f2b2a-b199-48d2-8e52-c626e2160842)
- [FDA Inspection 971348 - 2016-05-24](https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/0dc82664-31e2-4812-8187-013c73515fb8)

Company: https://www.keypedia.com/companies/delta-pharma-inc/02691b3f-ea7e-4c24-b039-09e433a9df05

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c